久久久久免费_精品国产乱码久久久久久久软件_欧美一区亚洲一区_国产一区二区三区高清在线观看_欧美日在线观看_成人网av

美國西格瑪奧德里奇Sigma-Aldrich   
sigma-aldrich是全球最大的化工試劑生產(chǎn)商,Sigma-Aldrich 是一個(gè)生物/ 化學(xué)試劑領(lǐng)先的高科技企業(yè)。我們的生化試劑, 有機(jī)化學(xué)試劑和試劑盒廣泛應(yīng)用于基因組學(xué)研究,生物科技,藥物研發(fā),疾病診斷和化工生產(chǎn)上. 我們的客戶遍及生命科學(xué)公司,大學(xué), 研究機(jī)構(gòu),醫(yī)院以及工業(yè)部門. 其客戶遍及160個(gè)國家地區(qū)，在35個(gè)國家有分支機(jī)構(gòu),雇員超過6,800人.
美國Sigma-Aldrich公司（美國西格瑪奧德里奇公司）是一家致力于生命科學(xué)與化學(xué)領(lǐng)域的高科技跨國公司，是世界上最大的化學(xué)/生物試劑生產(chǎn)商和供應(yīng)商，也是全球數(shù)以百萬計(jì)的科學(xué)家和技術(shù)人員的實(shí)驗(yàn)伙伴。其生物化學(xué)、有機(jī)化學(xué)試劑及試劑盒，廣泛應(yīng)用于基因組、蛋白質(zhì)組研究、生物科技、藥業(yè)、疾病診斷和化工生產(chǎn)，產(chǎn)品數(shù)量超過120,000種。 美國Sigma-Aldrich公司在全球34個(gè)國家設(shè)立了分公司或辦事處，并在9個(gè)國家設(shè)立了31個(gè)生產(chǎn)基地，全球員工6800余人。公司致力于提供高精尖的科學(xué)技術(shù)與產(chǎn)品，以卓越的品質(zhì)以及優(yōu)質(zhì)的服務(wù)，加速研究者的成功步伐。

2006年4月1日美國Sigma-Aldrich公司在中國投資成立了一家獨(dú)資企業(yè)西格瑪奧德里奇（上海）貿(mào)易有限公司Sigma-Aldrich(Shanghai) Trading Co，Ltd, 并購了中國主要的經(jīng)銷商，率先在中國實(shí)現(xiàn)直銷的銷售模式。同時(shí)，公司設(shè)立了免費(fèi)呼叫中心-- 800-819-3336，提供產(chǎn)品訂購與技術(shù)咨詢服務(wù)。公司努力提高營運(yùn)服務(wù)水平，在上海和北京有約４000多平米的高規(guī)格倉庫，備有大量的庫存，產(chǎn)品涵蓋了生物化學(xué)、有機(jī)化學(xué)、分析化學(xué)各個(gè)領(lǐng)域。

Supelco和Fluka/RdH是美國Sigma-Aldrich公司旗下的兩大著名品牌, 致力于分析化學(xué)領(lǐng)域的產(chǎn)品研制開發(fā), 生產(chǎn)銷售和技術(shù)服務(wù)等。

美國Supelco品牌專注于色譜分離和樣品前處理, 其可提供的產(chǎn)品有:
氣相色譜柱及配件
液相色譜柱和配件
固相萃取(SPE)裝置及小柱
固相微萃取(SPME)手柄及萃取頭
空氣監(jiān)測產(chǎn)品(溶劑解析管,熱解析管,吹掃捕集吸附管,被動(dòng)擴(kuò)散采樣吸附管)
分析標(biāo)準(zhǔn)品和色譜進(jìn)樣瓶等

瑞士Fluka/德國RdH品牌專注于分析試劑和標(biāo)準(zhǔn)品, 其可提供的產(chǎn)品有:
衍生化試劑
卡爾費(fèi)休水分測定試劑
HPLC溶劑
農(nóng)殘溶劑
高純度酸/堿/鹽
離子對試劑
當(dāng)量標(biāo)準(zhǔn)溶液
染料/指示劑
微生物培養(yǎng)基
各種分析標(biāo)準(zhǔn)品(GC/HPLC/AAS/ICP)等

Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Sigma-Aldrich operates in 35 countries and has over 6,800 employees providing excellent service worldwide.
 
he Story of Sigma-Aldrich
Sigma-Aldrich is the world's largest supplier of research biochemical and organic chemicals. Every day more than one million customers around the globe count on Sigma-Aldrich for quality products delivered on time and as promised.
A trusted leader in life science, high technology and service, the story of Sigma-Aldrich has a rich history of innovation.
Sigma? Chemical Company
The company's roots spring from 1934 in St. Louis, MO, when two brothers, Aaron Fischer and Bernard Fischlowitz, launched a small consulting firm. The two chemical engineers named their partnership Midwest Consultants – parent company of Sigma Chemical Company – and began to help St. Louis businesses produce a variety of specialty products including cosmetics, shoe dressings, and adhesives and inks for cardboard packaging. The firm incorporated in 1935 and hired Dan Broida, another chemical engineer out of Washington University in St. Louis, to manage the company's growing consulting and production businesses.
During World War II, Midwest manufactured ammunition components and made felt and paper parts for signal flares. In addition, saccharin was in high demand and short supply. To fill the need, Broida formed Sigma Chemical Company as a division of Midwest Consultants. For a year, major distributing companies bought saccharin as fast as Sigma could produce it. When the war ended, however, supplies of many raw materials again became plentiful and effectively forced Sigma out of the market.
In its search for a new direction, Sigma's turn toward research biochemicals came in the form of Lou Berger, a friend of Broida who had completed a MS degree in biochemistry at the Washington University in St. Louis School of Medicine under Nobel Laureates Carl and Gerty Cori. As a graduate student, one of Berger's tasks had been to extract adenosine triphosphate (ATP) from rabbit muscle. ATP is a major source of energy in living organisms and was used extensively in the Cori's research. The Coris and other biomedical researchers at this time were involved in studies requiring ATP in quantity. Berger suggested that Sigma produce the compound on a larger scale and taught his process to Sigma personnel. A small ad in a scientific journal brought orders and Broida expanded production. Within two years, Sigma offered eight additional ATP derivatives and raised purity levels.
Sigma entered the next decades with broad expansion into biochemicals and clinical products. In 1964, Sigma London was formed to establish a more active position in the market in Great Britain. Two more foreign subsidiaries were formed – Sigma Israel (1970) and Sigma Munich in West Germany (1974).
Aldrich Chemical Co.
Alfred R. Bader, an Austrian immigrant and chemistry graduate student at Harvard University, entertained the idea of starting a company to sell research chemicals in 1949. Acting on the premise that chemists needed a wider array of research chemicals and better service, Bader and attorney Jack Eisendrath founded Aldrich Chemical Company in Milwaukee, WI, in 1951.
Aldrich offered 1-methyl-3-nitro-1-nitrosofuanidine (MNNG) as it first product, widely used as a methylating reagent. Other products offered in the early '50s include 3-hydroxypyridine, which later became one of Aldrich's best-selling products; ethyl diazoacetate; tetranitomethane; and ethanedithiol. From 1951 to 1954, Bader developed important collaborations through visits to chemical producers in Europe and the UK. The remainder of the 1950s was characterized by rapid growth in sales and in the number of products offered.
Aldrich's Rare Chemical Library (RCL) grew out of the collecting and salvaging of valuable research samples of retiring or deceased academic researchers and from other sources. Large-scale contributions of samples to the library have come from such noteworthy chemists as Henry Gilman, George Wittig, Robert Woodward, and Louis and Mary Fieser. RCL has led to the discovery and commercialization by others of some valuable chemical commodities, e.g., Roundup? (Monsanto Co.), based on lead compounds obtained from the RCL.
The late '50s and early '60s witnessed the growing importance of custom synthesis and bulk sales at Aldrich. Over the years, these functions evolved into Sigma-Aldrich Fine Chemicals (SAFC), currently one of four strategic business units within Sigma-Aldrich Corporation.
A significant opportunity in the 1970s came when Professor H. C. Brown of Purdue University asked Aldrich to further develop and commercialize the hydroboration technology and organoborane chemistry that he had developed and patented. This led to the establishment of Aldrich-Boranes, Inc., a wholly owned Aldrich subsidiary created to manufacture hydroboration reagents and products. Some of the first compounds manufactured by Aldrich-Boranes were borane-THF, 9-BBN, and borane-methyl sulfide.
Sigma-Aldrich Corporation
When changing trends in chemical research confirmed the synergy to be realized from their complementary product offerings (approximately 40,000 in total at the time), Aldrich Chemical Co. merged with Sigma International, Ltd. to form Sigma-Aldrich Corporation in 1975. With this marriage of broad capabilities and resources, annual double-digit growth would become the standard in the 1980s and 1990s, with significant expansion in facilities, major acquisitions and ventures into new market sectors paving the way into the 21st century.
Sigma-Aldrich's international expansion took off in the 1980s with the opening of subsidiaries in France, Belgium, Japan, Italy, Netherlands and Spain. The acquisition of Biomakor in Israel in 1986 and Fluka in 1989 in Switzerland strengthened this rapid expansion. Sigma-Aldrich continued to increase its international presence greatly during the 1990s, opening 20 offices during that decade either by acquisition or by establishing a subsidiary. In Scandinavia, Sigma-Aldrich acquired four of its dealers, which became Sigma-Aldrich Sweden, Norway, Finland and Denmark. Following the fall of the Berlin Wall, the Company took advantage of the opening of these new markets by opening subsidiaries in Poland, Czech Republic, Hungary and by acquiring a dealer in Russia. Beginning to establish a presence in the area now known as CAPLA (Canada, Asia Pacific and Latin America), Sigma-Aldrich opened offices and distribution warehouses in Australia, followed by India, South Korea, Singapore and Malaysia, as well as Canada, Mexico, Brazil and Argentina in the Americas. This was only the beginning.
From the acquisiton of Supelco in 1993 and Riedel de Haen in 1997, each increasing Sigma-Aldrich's analytical and chromatography capabilities, the Company continued its growth strategy. The year 1999 brought with it the Company's first strategic plan, with Davd Harvey now at the helm as CEO, taking over for Tom Cori. By the next year, Sigma-Aldrich hit the $1 billion in sales milestone, with 6,000 employees in 33 countries – well-known and trusted worldwide.
In 2001, Sigma-Aldrich acquired Isotec, a leader in stable isotope production whose products are used in basic research and the diagnosis of disease. That same year, the Company opened its $55 million Life Science and High Technology Center in St. Louis. In 2004, Ultrafine, a supplier of contract manufacturing services for drug development, and Tetrionics, a producer of high potency and cytotoxic active pharmaceutical ingredients, became a strategic piece of the Company's portfolio. The following year, Sigma-Aldrich underwent its second strageic plan review, announcing the formation of four customer-centric business units and a strong focus on geographic expansion, Internet sales and process improvement to propel the Company to even greater heights. Jai Nagarkatti, former president of Aldrich, then became president and CEO of Sigma-Aldrich.
Sigma-Aldrich acquired JRH Biosciences (now SAFC Biosciences), a major industrial supplier of cell culture products for the pharmaceutical and biotechnology industries, and the Proligo Group, a global supplier of key genomics research tools. Also in 2005, Sigma-Aldrich announced membership in The RNAi Consortium and joined leading institutions including MIT, Harvard, and Eli Lilly to develop and distribute genome-wide shRNA libraries globally.
Sigma-Aldrich once again increased its global reach through the acquisitions of Beijing Superior Chemicals and Instruments Co. in China, Iropharm in Ireland, and Pharmorphix Ltd. in the UK. Other strategic acquistions would soon follow: Epichem Group Ltd. to expand capabilities in materials sciences and semiconductor markets, and Molecular Medicine BioServices to provide large-scale viral manufacturing capabilities.
In 2007, Sigma-Aldrich achieved another significant milestone by exceeding $2 billion in sales, delivering record earnings and further strengthening its leadership in the markets it serves. The strategic plan was proving to be quite successful, paving the way for a renewed focus the following year through the Company's third strategic plan.
More recently, Sigma-Aldrich acquired ChemNavigator in 2009 to provide researchers with industry-leading chemical compound selection and procurement services. That same year, the Company introduced CompoZr? Zinc Finger Technology and Sigma Advanced Genetic Engineering (SAGE?) Labs to offer next-generation rodent research models that can provide new insight into human disease. Sage Labs' targeted knockout rat ranked among The Scientist magazine's top five innovations of 2009.
In the decades since the 1975 merger, the Company has generated exceptional growth and continues to undergo many positive changes to drive Sigma-Aldrich into the future of science and technology. One such change has been the rise of the Internet and e-commerce, now accounting for approximately 45% of all research sales to become the Company's most powerful marketing tool. In addition, as Sigma-Aldrich continually increases its global reach, approximately 65% of sales stem from outside of the U.S.
Our future success requires more innovative products, faster technologies, and more sophisticated tools that support our customers' success. To accomplish this, our Company has new strategic initiatives that are expected to drive innovation and expand into new markets by leveraging our core scientific strengths: Analytical Chemistry, Biology, and Chemistry-Materials Science (ABCM). Our ABCM initiatives will help us expand our product offering, open new markets and enhance our position in the areas we know best.
Today, Sigma-Aldrich has a broad offering of more than 130,000 chemical products (48,000 of which the Company manufactures) and 40,000 equipment items. We supply products to customers in over 150 countries around the world through state-of-the-art distribution centers. With a committed workforce of approximately 8,000 employees in 38 countries, Sigma-Aldrich has the unrivalled scientific knowledge, unsurpassed service, and global reach to serve researchers and technologists and to ultimately improve quality of life.